MK-0773
id:
mk-0773-194-3032851
title:
MK-0773
text:
MK-0773, also known as PF-05314882, is a steroidal, orally active selective androgen receptor modulator (SARM) that was under development by Merck and GTx for the treatment of sarcopenia (loss of muscle mass) in women and men. Clinical trials for sarcopenia began in late 2007 but the collaboration between Merck and GTx ended in early 2010 and GTx terminated development of MK-0773 shortly thereafter. MK-0773 was developed as a more advanced version of the related compound TFM-4AS-1. MK-0773 is a
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/MK-0773
date created:
date modified:
2024-02-05T03:24:56Z
main entity:
{"identifier":"Q27261459","url":"https://www.wikidata.org/entity/Q27261459"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/5/5d/MK-0773.svg","width":1810,"height":1240}
fields total:
13
integrity:
15